These findings lead us to conclude that the anticancer effects of H. zeylanica-E2 in GC cells can be partly ascribed to TNF-α activation of the proinflammatory cPLA2-COX-2-PGE2 pathway. The gene discussed is TNF; the disease is gastric cancer.